DNA-Packing Portal and Capsid-Associated Tegument Complexes in the Tumor Herpesvirus KSHV.


Journal

Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066

Informations de publication

Date de publication:
05 09 2019
Historique:
received: 07 02 2019
revised: 16 05 2019
accepted: 17 07 2019
pubmed: 27 8 2019
medline: 17 6 2020
entrez: 27 8 2019
Statut: ppublish

Résumé

Assembly of Kaposi's sarcoma-associated herpesvirus (KSHV) begins at a bacteriophage-like portal complex that nucleates formation of an icosahedral capsid with capsid-associated tegument complexes (CATCs) and facilitates translocation of an ∼150-kb dsDNA genome, followed by acquisition of a pleomorphic tegument and envelope. Because of deviation from icosahedral symmetry, KSHV portal and tegument structures have largely been obscured in previous studies. Using symmetry-relaxed cryo-EM, we determined the in situ structure of the KSHV portal and its interactions with surrounding capsid proteins, CATCs, and the terminal end of KSHV's dsDNA genome. Our atomic models of the portal and capsid/CATC, together with visualization of CATCs' variable occupancy and alternate orientation of CATC-interacting vertex triplexes, suggest a mechanism whereby the portal orchestrates procapsid formation and asymmetric long-range determination of CATC attachment during DNA packaging prior to pleomorphic tegumentation/envelopment. Structure-based mutageneses confirm that a triplex deep binding groove for CATCs is a hotspot that holds promise for antiviral development.

Identifiants

pubmed: 31447177
pii: S0092-8674(19)30834-7
doi: 10.1016/j.cell.2019.07.035
pmc: PMC6753055
mid: NIHMS1539076
pii:
doi:

Substances chimiques

Capsid Proteins 0
DNA, Viral 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1329-1343.e12

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI094386
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE023591
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE025567
Pays : United States
Organisme : NCRR NIH HHS
ID : S10 RR023057
Pays : United States
Organisme : NIGMS NIH HHS
ID : U24 GM116792
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM071940
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE027901
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA177322
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA091791
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE028583
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Références

EMBO J. 2007 Apr 4;26(7):1984-94
pubmed: 17363899
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):2778-83
pubmed: 9501166
Methods Enzymol. 2016;579:125-57
pubmed: 27572726
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19123-7
pubmed: 17146053
Cell. 2019 Jan 10;176(1-2):281-294.e19
pubmed: 30503209
J Virol. 2008 Jul;82(14):7201-11
pubmed: 18463150
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
Nat Commun. 2015 Jul 06;6:7548
pubmed: 26144253
J Virol. 2017 Jul 12;91(15):
pubmed: 28515293
Science. 2017 Jun 30;356(6345):
pubmed: 28663444
J Virol. 2009 Jul;83(13):6610-23
pubmed: 19386703
J Struct Biol. 2012 Dec;180(3):519-30
pubmed: 23000701
J Virol. 1994 Sep;68(9):6059-63
pubmed: 8057482
Drug Resist Updat. 2002 Apr;5(2):88-114
pubmed: 12135584
J Virol. 2011 Feb;85(4):1871-4
pubmed: 21106752
PLoS Biol. 2011 Nov;9(11):e1001196
pubmed: 22110401
Nat Methods. 2014 Jan;11(1):63-5
pubmed: 24213166
Emerg Infect Dis. 2004 Feb;10(2):320-6
pubmed: 15030705
Nat Protoc. 2015 Jun;10(6):845-58
pubmed: 25950237
Ultramicroscopy. 2000 Mar;81(2):83-98
pubmed: 10998793
J Hosp Infect. 1996 Aug;33(4):235-48
pubmed: 8864937
Science. 2018 Apr 6;360(6384):
pubmed: 29622628
J Virol. 2007 Feb;81(4):2065-8
pubmed: 17151101
Nature. 2018 Jan 25;553(7689):521-525
pubmed: 29342139
J Gen Virol. 1994 May;75 ( Pt 5):1101-13
pubmed: 8176371
Viruses. 2015 Sep 18;7(9):5084-114
pubmed: 26393641
Adv Exp Med Biol. 2012;726:423-39
pubmed: 22297525
Structure. 2014 Oct 7;22(10):1385-98
pubmed: 25220471
J Virol. 2001 Feb;75(3):1427-36
pubmed: 11152516
J Mol Biol. 2003 Oct 31;333(4):721-45
pubmed: 14568533
J Virol. 2000 Oct;74(20):9646-54
pubmed: 11000237
Proc Natl Acad Sci U S A. 2005 Apr 19;102(16):5832-7
pubmed: 15795370
J Virol. 2017 Jul 12;91(15):
pubmed: 28490590
Virology. 2007 May 10;361(2):426-34
pubmed: 17188319
J Virol. 2006 Mar;80(5):2309-17
pubmed: 16474137
J Gen Virol. 2017 Nov;98(11):2837-2849
pubmed: 29035172
J Virol. 2002 May;76(10):4785-91
pubmed: 11967295
J Virol. 2008 May;82(10):4742-50
pubmed: 18321973
Sci Adv. 2017 Jul 26;3(7):e1700423
pubmed: 28782023
J Struct Biol. 2008 Mar;161(3):419-27
pubmed: 18164626
Nat Commun. 2017 Jan 30;8:14310
pubmed: 28134243
J Virol. 2005 Aug;79(16):10540-6
pubmed: 16051846
J Clin Invest. 2010 Apr;120(4):939-49
pubmed: 20364091
Methods Mol Biol. 2017;1654:39-54
pubmed: 28986782
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Nat Methods. 2013 Jun;10(6):584-90
pubmed: 23644547
J Virol. 2014 Nov;88(21):12694-702
pubmed: 25142590
Adv Virus Res. 2014;88:111-59
pubmed: 24373311
Adv Anat Embryol Cell Biol. 2017;223:119-142
pubmed: 28528442
J Infect Dis. 2003 Sep 15;188(6):883-90
pubmed: 12964120
J Struct Biol. 2011 Sep;175(3):253-63
pubmed: 21627992
J Struct Biol. 2003 Jun;142(3):334-47
pubmed: 12781660
Front Microbiol. 2012 Mar 15;3:98
pubmed: 22435068
Nat Commun. 2018 Sep 10;9(1):3668
pubmed: 30201968
J Virol. 1998 Feb;72(2):1060-70
pubmed: 9445000
J Virol. 2012 Sep;86(18):9708-20
pubmed: 22740391
Cell Host Microbe. 2016 Nov 9;20(5):642-653
pubmed: 27832591
J Virol. 2001 Mar;75(6):2879-90
pubmed: 11222713
PLoS Biol. 2018 Jun 20;16(6):e2006191
pubmed: 29924793
J Virol. 2006 Mar;80(5):2118-26
pubmed: 16474120
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3086-91
pubmed: 11248036
J Virol. 2007 Jun;81(12):6419-33
pubmed: 17392365
J Struct Biol. 2018 Nov;204(2):313-318
pubmed: 30114513
Science. 1994 Dec 16;266(5192):1865-9
pubmed: 7997879

Auteurs

Danyang Gong (D)

Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095, USA.

Xinghong Dai (X)

Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095, USA; Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA.

Jonathan Jih (J)

California NanoSystems Institute (CNSI), University of California, Los Angeles, Los Angeles, CA 90095, USA.

Yun-Tao Liu (YT)

California NanoSystems Institute (CNSI), University of California, Los Angeles, Los Angeles, CA 90095, USA; Center for Integrative Imaging, Hefei National Laboratory for Physical Sciences at the Microscale, and School of Life Sciences, University of Science and Technology of China (USTC), Hefei, Anhui 230026, China.

Guo-Qiang Bi (GQ)

Center for Integrative Imaging, Hefei National Laboratory for Physical Sciences at the Microscale, and School of Life Sciences, University of Science and Technology of China (USTC), Hefei, Anhui 230026, China.

Ren Sun (R)

Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095, USA; California NanoSystems Institute (CNSI), University of California, Los Angeles, Los Angeles, CA 90095, USA. Electronic address: rsun@mednet.ucla.edu.

Z Hong Zhou (ZH)

Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA; California NanoSystems Institute (CNSI), University of California, Los Angeles, Los Angeles, CA 90095, USA. Electronic address: hong.zhou@ucla.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH